Journal Title：Drugs Of The Future

A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions.

The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.

一份領先的國際同行評議生物醫(yī)學研究期刊，發(fā)表化學、生物學、藥理學、基因組學和醫(yī)學等領域新興主題的文章，面向參與藥物設計、發(fā)現(xiàn)和開發(fā)、靶標識別和驗證以及常見、罕見和被忽視的疾病和病癥的治療的臨床前和臨床開發(fā)的科學家和研究人員。

該期刊發(fā)表的專著包含有關正在開發(fā)的新化合物的全面產(chǎn)品信息，包括合成、臨床前藥理學、藥代動力學和代謝、安全性、臨床研究和藥物相互作用，以及各種主題的評論文章、大會和會議報告。

Drugs Of The Future創(chuàng)刊于1976年，由Prous Science出版商出版，收稿方向涵蓋醫(yī)學 - 藥學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 較慢,6-12周 ，該期刊近期被列入國際期刊預警名單，請廣大學者慎重選擇。